Drug-class overview:@0.657199:0.039086:0.902803:0.039086:0.902803:0.019651:0.657199:0.019651:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
11:@0.950592:0.038665:0.976698:0.038665:0.976698:0.018632:0.950592:0.018632:0.000000:0.000000
Drug-class overview:@0.981851:0.292741:0.981851:0.109337:0.953582:0.109337:0.953582:0.292741:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS :@0.216640:0.974259:0.820834:0.974259:0.820834:0.960936:0.216640:0.960936:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.820834:0.974259:0.824580:0.974259:0.824580:0.960936:0.820834:0.960936:0.000000
VOLUME 1:@0.824751:0.974259:0.906065:0.974259:0.906065:0.959690:0.824751:0.959690:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
concentration as hypokalaemia may predispose :@0.096970:0.096562:0.479990:0.096562:0.479990:0.081574:0.096970:0.081574:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
patients  to  arrhythmia :@0.096970:0.112213:0.307077:0.112213:0.307077:0.097224:0.096970:0.097224:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.324896:0.111697:0.333709:0.111697:0.333709:0.097012:0.324896:0.097012:0.000000
 Symptoms  of :@0.333709:0.112213:0.479990:0.112213:0.479990:0.097224:0.333709:0.097224:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
hyperthyroidism and hypoglycaemia possibly :@0.096989:0.127863:0.479970:0.127863:0.479970:0.112874:0.096989:0.112874:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
masked   Myasthenia gravis possibly unmasked  :@0.096989:0.143513:0.479990:0.143513:0.479990:0.128524:0.096989:0.128524:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.163741:0.142997:0.172554:0.142997:0.172554:0.128312:0.163741:0.128312:0.000000
:@0.096989:0.158647:0.105802:0.158647:0.105802:0.143963:0.096989:0.143963:0.000000
 Psoriasis possibly aggravated:@0.105802:0.159163:0.331323:0.159163:0.331323:0.144174:0.105802:0.144174:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
alpha and beta receptor blockers :@0.096970:0.187930:0.469605:0.187930:0.469605:0.166375:0.096970:0.166375:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Carvedilol and labetalol are non-selective :@0.096970:0.202479:0.479970:0.202479:0.479970:0.187490:0.096970:0.187490:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
β-receptor (β  and β ) and α-receptor blockers :@0.096970:0.218129:0.479991:0.218130:0.479991:0.203141:0.096970:0.203140:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.202334:0.221156:0.207809:0.221156:0.207809:0.212418:0.202334:0.212418:0.000000
2:@0.264890:0.221156:0.270364:0.221156:0.270364:0.212418:0.264890:0.212418:0.000000
blocking the  β-receptors  in  the heart and :@0.096971:0.233780:0.479972:0.233780:0.479972:0.218792:0.096971:0.218792:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
α-receptors in the vascular smooth muscle.:@0.096971:0.249430:0.426074:0.249430:0.426074:0.234442:0.096971:0.234442:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
10 :@0.426067:0.243648:0.439473:0.243648:0.439473:0.234910:0.426067:0.234910:0.000000:0.000000:0.000000
Carvedilol:@0.096970:0.278195:0.206395:0.278195:0.206395:0.256640:0.096970:0.256640:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Indications::@0.096970:0.297204:0.197357:0.297204:0.197357:0.280813:0.096970:0.280813:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.197355:0.291420:0.203582:0.291420:0.203582:0.281864:0.197355:0.281864:0.000000
Mild to moderate essential hypertension   Mild :@0.096970:0.312856:0.480028:0.312856:0.480028:0.297867:0.096970:0.297867:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.426015:0.312340:0.434828:0.312340:0.434828:0.297655:0.426015:0.297655:0.000000
to moderate stable symptomatic heart failure of :@0.096970:0.328506:0.479970:0.328506:0.479970:0.313517:0.096970:0.313517:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
ischaemic cardiomyopathy origin: in conjunction :@0.096970:0.344156:0.479990:0.344156:0.479990:0.329167:0.096970:0.329167:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
with standard therapy:@0.096970:0.359806:0.265879:0.359806:0.265879:0.344817:0.096970:0.344817:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage::@0.096970:0.379914:0.166396:0.379914:0.166396:0.363523:0.096970:0.363523:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.166396:0.374137:0.172622:0.374137:0.172622:0.364581:0.166396:0.364581:0.000000
take after meals   essential hypertension:  adults: :@0.096970:0.395573:0.479970:0.395573:0.479970:0.380584:0.096970:0.380584:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.224989:0.395057:0.233802:0.395057:0.233802:0.380373:0.224989:0.380373:0.000000
Initial dose: 6.25 mg twice daily for 1-2 weeks, with :@0.096970:0.411223:0.479951:0.411223:0.479951:0.396235:0.096970:0.396235:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
maintenance of 12.5 mg twice daily or 12.5 mg :@0.096970:0.426873:0.479951:0.426873:0.479951:0.411885:0.096970:0.411885:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
once daily for two days with maintenance of :@0.096970:0.442523:0.479990:0.442523:0.479990:0.427535:0.096970:0.427535:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
25  mg  once daily.  elderly:  Initial:  12.5  mg  once :@0.096970:0.458173:0.479932:0.458173:0.479932:0.443185:0.096970:0.443185:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
daily.  If  necessary,  increase  dose  as  tolerated  at :@0.096970:0.473824:0.479913:0.473824:0.479913:0.458835:0.096970:0.458835:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
two-week intervals up to 25 mg once daily or in :@0.096970:0.489474:0.480028:0.489474:0.480028:0.474485:0.096970:0.474485:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
divided doses   CHF in conjunction with standard :@0.096970:0.505124:0.479970:0.505124:0.479970:0.490135:0.096970:0.490135:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.206613:0.504608:0.215426:0.504608:0.215426:0.489923:0.206613:0.489923:0.000000
therapy: Initial dose: 3.125 mg twice daily for two :@0.096970:0.520774:0.479970:0.520774:0.479970:0.505785:0.096970:0.505785:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
weeks then increase to 6.25 mg twice daily for :@0.096970:0.536424:0.479913:0.536424:0.479913:0.521435:0.096970:0.521435:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
two weeks. Maximum dose: 25 mg twice daily in :@0.096970:0.552074:0.479932:0.552074:0.479932:0.537085:0.096970:0.537085:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
patients less than 85 kg and 50 mg twice daily in :@0.096970:0.567724:0.480028:0.567724:0.480028:0.552736:0.096970:0.552736:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
those more than 85 kg:@0.096970:0.583374:0.270536:0.583374:0.270536:0.568386:0.096970:0.568386:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications::@0.096970:0.603483:0.254757:0.603483:0.254757:0.587092:0.096970:0.587092:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.254755:0.597717:0.260981:0.597717:0.260981:0.588161:0.254755:0.588161:0.000000
bronchospasm    asthma    obstructive airway :@0.096970:0.619153:0.479970:0.619153:0.479970:0.604164:0.096970:0.604164:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.221025:0.618637:0.229838:0.618637:0.229838:0.603952:0.221025:0.603952:0.000000
:@0.308309:0.618637:0.317122:0.618637:0.317122:0.603952:0.308309:0.603952:0.000000
disease history   bronchitis   Chronic respiratory :@0.096970:0.634803:0.479970:0.634803:0.479970:0.619814:0.096970:0.619814:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.217215:0.634287:0.226028:0.634287:0.226028:0.619603:0.217215:0.619603:0.000000
:@0.313524:0.634287:0.322337:0.634287:0.322337:0.619603:0.313524:0.619603:0.000000
disease   Second- or third-degree  av block :@0.096970:0.650453:0.480028:0.650453:0.480028:0.635464:0.096970:0.635464:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.165857:0.649937:0.174670:0.649937:0.174670:0.635253:0.165857:0.635253:0.000000
 :@0.475776:0.650453:0.479990:0.650453:0.479990:0.635464:0.475776:0.635464:0.000000
:@0.096989:0.665587:0.105802:0.665587:0.105802:0.650903:0.096989:0.650903:0.000000
 Severe bradycardia (less than 50 bpm)   new :@0.105802:0.666103:0.480009:0.666103:0.480009:0.651114:0.105802:0.651114:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.424456:0.665587:0.433269:0.665587:0.433269:0.650903:0.424456:0.650903:0.000000
York Heart  association class Iv decomposition :@0.097008:0.681753:0.480009:0.681753:0.480009:0.666765:0.097008:0.666765:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
HF requiring Iv inotropic support   Cardiogenic :@0.097008:0.697403:0.480009:0.697403:0.480009:0.682415:0.097008:0.682415:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.367422:0.696887:0.376235:0.696887:0.376235:0.682203:0.367422:0.682203:0.000000
shock   Sick-sinus syndrome, including Sa block :@0.097008:0.713053:0.479970:0.713053:0.479970:0.698065:0.097008:0.698065:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.147577:0.712537:0.156390:0.712537:0.156390:0.697853:0.147577:0.697853:0.000000
:@0.097008:0.728188:0.105821:0.728188:0.105821:0.713503:0.097008:0.713503:0.000000
 Hepatic function impairment   Metabolic :@0.105821:0.728703:0.480028:0.728703:0.480028:0.713715:0.105821:0.713715:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.376350:0.728188:0.385163:0.728188:0.385163:0.713503:0.376350:0.713503:0.000000
acidosis   Peripheral vascular disease   raynaud’s :@0.097027:0.744354:0.480067:0.744354:0.480067:0.729365:0.097027:0.729365:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.162317:0.743838:0.171130:0.743838:0.171130:0.729153:0.162317:0.729153:0.000000
:@0.385798:0.743838:0.394611:0.743838:0.394611:0.729153:0.385798:0.729153:0.000000
phenomenon    allergic conditions involving :@0.097066:0.760004:0.480067:0.760004:0.480067:0.745015:0.097066:0.745015:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.217389:0.759488:0.226202:0.759488:0.226202:0.744803:0.217389:0.744803:0.000000
airways   Pregnancy   lactation   Children:@0.097066:0.775654:0.423398:0.775654:0.423398:0.760665:0.097066:0.760665:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.158449:0.775138:0.167262:0.775138:0.167262:0.760453:0.158449:0.760453:0.000000
:@0.256835:0.775138:0.265648:0.775138:0.265648:0.760453:0.256835:0.760453:0.000000
:@0.345408:0.775138:0.354221:0.775138:0.354221:0.760453:0.345408:0.760453:0.000000
Side effects::@0.097066:0.795762:0.200282:0.795762:0.200282:0.779371:0.097066:0.779371:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.200184:0.789994:0.206411:0.789994:0.206411:0.780438:0.200184:0.780438:0.000000
blood dyscrasia   Hypo- or hyperglycaemia   overt :@0.096970:0.811430:0.479970:0.811430:0.479970:0.796441:0.096970:0.796441:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.216022:0.810914:0.224835:0.810914:0.224835:0.796229:0.216022:0.796229:0.000000
:@0.421089:0.810914:0.429902:0.810914:0.429902:0.796229:0.421089:0.796229:0.000000
psychosis   Fatigue   dizziness   Paraesthesia   CnS :@0.096970:0.827080:0.479970:0.827080:0.479970:0.812091:0.096970:0.812091:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.172708:0.826564:0.181521:0.826564:0.181521:0.811879:0.172708:0.811879:0.000000
:@0.242384:0.826564:0.251197:0.826564:0.251197:0.811879:0.242384:0.811879:0.000000
:@0.325396:0.826564:0.334209:0.826564:0.334209:0.811879:0.325396:0.811879:0.000000
:@0.432673:0.826564:0.441486:0.826564:0.441486:0.811879:0.432673:0.811879:0.000000
effects   Hallucinations   Peripheral neuropathy :@0.096970:0.842730:0.479970:0.842730:0.479970:0.827741:0.096970:0.827741:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.154754:0.842214:0.163567:0.842214:0.163567:0.827530:0.154754:0.827530:0.000000
:@0.286276:0.842214:0.295089:0.842214:0.295089:0.827530:0.286276:0.827530:0.000000
:@0.096970:0.857864:0.105783:0.857864:0.105783:0.843180:0.096970:0.843180:0.000000
  decreased tear production    blurred vision :@0.105783:0.858380:0.480009:0.858380:0.480009:0.843391:0.105783:0.843391:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.345851:0.857864:0.354664:0.857864:0.354664:0.843180:0.345851:0.843180:0.000000
 :@0.475776:0.858380:0.479990:0.858380:0.479990:0.843391:0.475776:0.843391:0.000000
:@0.096989:0.873514:0.105802:0.873514:0.105802:0.858830:0.096989:0.858830:0.000000
 ocular pain   Marked bradycardia   Hypotension :@0.105802:0.874030:0.479990:0.874030:0.479990:0.859041:0.105802:0.859041:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.199108:0.873514:0.207921:0.873514:0.207921:0.858830:0.199108:0.858830:0.000000
:@0.364901:0.873514:0.373714:0.873514:0.373714:0.858830:0.364901:0.858830:0.000000
:@0.096989:0.889164:0.105802:0.889164:0.105802:0.874480:0.096989:0.874480:0.000000
 Chest pain   General oedema   Heart block with :@0.105802:0.889680:0.480009:0.889680:0.480009:0.874692:0.105802:0.874692:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.194375:0.889164:0.203188:0.889164:0.203188:0.874480:0.194375:0.874480:0.000000
:@0.337731:0.889164:0.346544:0.889164:0.346544:0.874480:0.337731:0.874480:0.000000
possible  precipitation  with  underlying  cardiac :@0.096989:0.905330:0.479951:0.905330:0.479951:0.890342:0.096989:0.890342:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
conditions    exacerbated  peripheral  vascular :@0.096989:0.920980:0.479970:0.920980:0.479970:0.905992:0.096989:0.905992:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.191681:0.920464:0.200494:0.920464:0.200494:0.905780:0.191681:0.905780:0.000000
disease   raynaud’s  phenomenon   Congestive :@0.096989:0.936631:0.479990:0.936631:0.479990:0.921642:0.096989:0.921642:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.160335:0.936115:0.169148:0.936115:0.169148:0.921430:0.160335:0.921430:0.000000
:@0.373618:0.936115:0.382431:0.936115:0.382431:0.921430:0.373618:0.921430:0.000000
cardiac failure   dyspnoea   Pharyngitis   rhinitis :@0.524266:0.096830:0.907267:0.096830:0.907267:0.081841:0.524266:0.081841:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.635026:0.096314:0.643839:0.096314:0.643839:0.081630:0.635026:0.081630:0.000000
:@0.730757:0.096314:0.739570:0.096314:0.739570:0.081630:0.730757:0.081630:0.000000
:@0.833896:0.096314:0.842709:0.096314:0.842709:0.081630:0.833896:0.081630:0.000000
:@0.524266:0.111885:0.533079:0.111885:0.533079:0.097200:0.524266:0.097200:0.000000
  bronchoconstriction   Patients  suffering from :@0.533079:0.112401:0.907286:0.112401:0.907286:0.097412:0.533079:0.097412:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.705511:0.111885:0.714324:0.111885:0.714324:0.097200:0.705511:0.097200:0.000000
asthma or bronchitis or other chronic pulmonary :@0.524286:0.127971:0.907306:0.127971:0.907306:0.112983:0.524286:0.112983:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
diseases   Pneumonitis   Pulmonary fibrosis :@0.524286:0.143542:0.907306:0.143542:0.907306:0.128553:0.524286:0.128553:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.600466:0.143026:0.609279:0.143026:0.609279:0.128342:0.600466:0.128342:0.000000
:@0.731392:0.143026:0.740205:0.143026:0.740205:0.128342:0.731392:0.128342:0.000000
:@0.524305:0.158597:0.533118:0.158597:0.533118:0.143912:0.524305:0.143912:0.000000
 Pleurisy   GI disturbances   Hepatic injury :@0.533118:0.159113:0.907306:0.159113:0.907306:0.144124:0.533118:0.144124:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.613590:0.158597:0.622403:0.158597:0.622403:0.143912:0.613590:0.143912:0.000000
:@0.769684:0.158597:0.778497:0.158597:0.778497:0.143912:0.769684:0.143912:0.000000
 :@0.903092:0.159113:0.907306:0.159113:0.907306:0.144124:0.903092:0.144124:0.000000
:@0.524305:0.174168:0.533118:0.174168:0.533118:0.159483:0.524305:0.159483:0.000000
 Increased sweating    allergic skin reactions :@0.533118:0.174683:0.907306:0.174683:0.907306:0.159695:0.533118:0.159695:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.706819:0.174168:0.715632:0.174168:0.715632:0.159483:0.706819:0.159483:0.000000
 :@0.903092:0.174683:0.907306:0.174683:0.907306:0.159695:0.903092:0.159695:0.000000
:@0.524305:0.189738:0.533118:0.189738:0.533118:0.175054:0.524305:0.175054:0.000000
  alopecia    exacerbated psoriasis    back pain :@0.533118:0.190254:0.907306:0.190254:0.907306:0.175266:0.533118:0.175266:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.616264:0.189738:0.625077:0.189738:0.625077:0.175054:0.616264:0.175054:0.000000
:@0.809150:0.189738:0.817963:0.189738:0.817963:0.175054:0.809150:0.175054:0.000000
 :@0.903092:0.190254:0.907306:0.190254:0.907306:0.175266:0.903092:0.175266:0.000000
:@0.524305:0.205309:0.533118:0.205309:0.533118:0.190625:0.524305:0.190625:0.000000
  Myopathy    arthralgia    Muscular  weakness :@0.533118:0.205825:0.907306:0.205825:0.907306:0.190836:0.533118:0.190836:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.629214:0.205309:0.638027:0.205309:0.638027:0.190625:0.629214:0.190625:0.000000
:@0.731719:0.205309:0.740532:0.205309:0.740532:0.190625:0.731719:0.190625:0.000000
and cramps   Haematuria    deteriorating renal :@0.524324:0.221396:0.907325:0.221396:0.907325:0.206407:0.524324:0.206407:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.625558:0.220880:0.634371:0.220880:0.634371:0.206195:0.625558:0.206195:0.000000
:@0.738935:0.220880:0.747748:0.220880:0.747748:0.206195:0.738935:0.206195:0.000000
function in CCF patients   Impotence   Fever:@0.524324:0.236966:0.868840:0.236966:0.868840:0.221978:0.524324:0.221978:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.713015:0.236450:0.721828:0.236450:0.721828:0.221766:0.713015:0.221766:0.000000
:@0.814615:0.236450:0.823428:0.236450:0.823428:0.221766:0.814615:0.221766:0.000000
Special precautions::@0.524324:0.257009:0.696755:0.257009:0.696755:0.240618:0.524324:0.240618:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.696671:0.251276:0.702897:0.251276:0.702897:0.241720:0.696671:0.241720:0.000000
First control pheochromocytoma adequately with :@0.524242:0.272636:0.907262:0.272636:0.907262:0.257648:0.524242:0.257648:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
α-receptor blockers prior to starting treatment :@0.524242:0.288207:0.907262:0.288207:0.907262:0.273218:0.524242:0.273218:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524242:0.303262:0.533055:0.303262:0.533055:0.288577:0.524242:0.288577:0.000000
 First control CHF prior to starting treatment  :@0.533055:0.303778:0.907262:0.303778:0.907262:0.288789:0.533055:0.288789:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524261:0.318833:0.533074:0.318833:0.533074:0.304148:0.524261:0.304148:0.000000
 transforaminal clonidine   digitalisation maybe :@0.533074:0.319349:0.907281:0.319349:0.907281:0.304360:0.533074:0.304360:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.731271:0.318833:0.740084:0.318833:0.740084:0.304148:0.731271:0.304148:0.000000
necessary with long-term beta-blocker therapy if :@0.524280:0.334919:0.907281:0.334919:0.907281:0.319931:0.524280:0.319931:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
CCF is likely to develop   avoid with concomitant :@0.524280:0.350490:0.907262:0.350490:0.907262:0.335501:0.524280:0.335501:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.704370:0.349974:0.713183:0.349974:0.713183:0.335290:0.704370:0.335290:0.000000
cardiac-depressing:@0.524261:0.366061:0.669349:0.366061:0.669349:0.351072:0.524261:0.351072:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Ca:@0.694749:0.366061:0.714376:0.366061:0.714376:0.351072:0.694749:0.351072:0.000000:0.000000
2+:@0.714350:0.360308:0.726511:0.360308:0.726511:0.351569:0.714350:0.351569:0.000000:0.000000
channel:@0.751911:0.366092:0.813583:0.366092:0.813583:0.351104:0.751911:0.351104:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
blockers :@0.838983:0.366092:0.907235:0.366092:0.907235:0.351104:0.838983:0.351104:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524235:0.381147:0.533048:0.381147:0.533048:0.366463:0.524235:0.366463:0.000000
 Monitor digoxin level when adjusting carvedilol :@0.533048:0.381663:0.907216:0.381663:0.907216:0.366674:0.533048:0.366674:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524235:0.396718:0.533048:0.396718:0.533048:0.382033:0.524235:0.382033:0.000000
 Patients receiving digitalis, diuretics and or aCe :@0.533048:0.397234:0.907255:0.397234:0.907255:0.382245:0.533048:0.382245:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
inhibitors to be stabilised before initial therapy :@0.524254:0.412804:0.907255:0.412804:0.907255:0.397816:0.524254:0.397816:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903041:0.412804:0.907255:0.412804:0.907255:0.397816:0.903041:0.397816:0.000000
:@0.524254:0.427859:0.533067:0.427859:0.533067:0.413175:0.524254:0.413175:0.000000
 If therapy is discontinued for longer than two :@0.533067:0.428375:0.907293:0.428375:0.907293:0.413386:0.533067:0.413386:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
weeks in heart failure, initiate from starting :@0.524254:0.443946:0.907235:0.443946:0.907235:0.428957:0.524254:0.428957:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
point    do not increase dose until symptoms :@0.524254:0.459517:0.907216:0.459517:0.907216:0.444528:0.524254:0.444528:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.574496:0.459001:0.583309:0.459001:0.583309:0.444316:0.574496:0.444316:0.000000
of worsening HF or vasodilatation are stabilised :@0.524254:0.475087:0.907274:0.475087:0.907274:0.460099:0.524254:0.460099:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903041:0.475087:0.907255:0.475087:0.907255:0.460099:0.903041:0.460099:0.000000
:@0.524254:0.490142:0.533067:0.490142:0.533067:0.475458:0.524254:0.475458:0.000000
 discontinue 48 hrs prior to anaesthesia   Peri-:@0.533067:0.490658:0.903060:0.490658:0.903060:0.475669:0.533067:0.475669:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.853934:0.490142:0.862747:0.490142:0.862747:0.475458:0.853934:0.475458:0.000000
operative period    renal impairment    elderly :@0.524273:0.506229:0.907274:0.506229:0.907274:0.491240:0.524273:0.491240:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.665358:0.505713:0.674171:0.505713:0.674171:0.491028:0.665358:0.491028:0.000000
:@0.833960:0.505713:0.842773:0.505713:0.842773:0.491028:0.833960:0.491028:0.000000
 :@0.903060:0.506229:0.907274:0.506229:0.907274:0.491240:0.903060:0.491240:0.000000
:@0.524273:0.521284:0.533086:0.521284:0.533086:0.506599:0.524273:0.506599:0.000000
 discontinue gradually, particularly in ischaemic :@0.533086:0.521799:0.907255:0.521799:0.907255:0.506811:0.533086:0.506811:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
heart disease   Prinzmetal’s angina   Pulse rate :@0.524273:0.537370:0.907274:0.537370:0.907274:0.522382:0.524273:0.522382:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.635802:0.536854:0.644615:0.536854:0.644615:0.522170:0.635802:0.522170:0.000000
:@0.809773:0.536854:0.818586:0.536854:0.818586:0.522170:0.809773:0.522170:0.000000
less than 55 bpm   early signs and symptoms of :@0.524273:0.552941:0.907274:0.552941:0.907274:0.537952:0.524273:0.537952:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.665455:0.552425:0.674268:0.552425:0.674268:0.537741:0.665455:0.537741:0.000000
hypoglycaemia possibly masked   Possibly dosage :@0.524273:0.568512:0.907274:0.568512:0.907274:0.553523:0.524273:0.553523:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.771730:0.567996:0.780543:0.567996:0.780543:0.553311:0.771730:0.553311:0.000000
reduction of insulin or anti-diabetic medication :@0.524273:0.584082:0.907293:0.584082:0.907293:0.569094:0.524273:0.569094:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903060:0.584082:0.907274:0.584082:0.907274:0.569094:0.903060:0.569094:0.000000
:@0.524273:0.599137:0.533086:0.599137:0.533086:0.584453:0.524273:0.584453:0.000000
 Hyperthyroidism symptoms masked   Contact :@0.533086:0.599653:0.907293:0.599653:0.907293:0.584664:0.533086:0.584664:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.827283:0.599137:0.836096:0.599137:0.836096:0.584453:0.827283:0.584453:0.000000
lens wearing due to reduced lacrimation   Where :@0.524292:0.615224:0.907293:0.615224:0.907293:0.600235:0.524292:0.600235:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.840272:0.614708:0.849085:0.614708:0.849085:0.600024:0.840272:0.600024:0.000000
anaphylaxis history present, patients probably :@0.524292:0.630795:0.907274:0.630795:0.907274:0.615806:0.524292:0.615806:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
more reactive to repeat challenge with antigen:@0.524292:0.646365:0.884606:0.646365:0.884606:0.631377:0.524292:0.631377:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Drug interactions::@0.524292:0.666407:0.679251:0.666407:0.679251:0.650017:0.524292:0.650017:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.679199:0.660711:0.685425:0.660711:0.685425:0.651156:0.679199:0.651156:0.000000
Hypoglycaemic:@0.524242:0.682072:0.643853:0.682072:0.643853:0.667083:0.524242:0.667083:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
agents:@0.670888:0.682072:0.722862:0.682072:0.722862:0.667083:0.670888:0.667083:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.749878:0.681556:0.758691:0.681556:0.758691:0.666872:0.749878:0.666872:0.000000
Phenothiazines :@0.785727:0.682072:0.907262:0.682072:0.907262:0.667083:0.785727:0.667083:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524261:0.697127:0.533074:0.697127:0.533074:0.682442:0.524261:0.682442:0.000000
  anti-arrhythmic agents    nSaIds   Insulin :@0.533074:0.697643:0.907301:0.697643:0.907301:0.682654:0.533074:0.682654:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.742374:0.697127:0.751187:0.697127:0.751187:0.682442:0.742374:0.682442:0.000000
:@0.831659:0.697127:0.840472:0.697127:0.840472:0.682442:0.831659:0.682442:0.000000
 :@0.903086:0.697643:0.907301:0.697643:0.907301:0.682654:0.903086:0.682654:0.000000
:@0.524300:0.712697:0.533113:0.712697:0.533113:0.698013:0.524300:0.698013:0.000000
 Sulphonylureas   β-receptor blockers:@0.533113:0.713213:0.822076:0.713213:0.822076:0.698225:0.533113:0.698225:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.659535:0.712697:0.668348:0.712697:0.668348:0.698013:0.659535:0.698013:0.000000
Labetalol:@0.524242:0.741910:0.625560:0.741910:0.625560:0.720356:0.524242:0.720356:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Indications::@0.524242:0.760844:0.624630:0.760844:0.624630:0.744454:0.524242:0.744454:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.624628:0.755060:0.630854:0.755060:0.630854:0.745504:0.624628:0.745504:0.000000
rapid control of  bP in severe hypertension, :@0.524242:0.776420:0.907262:0.776420:0.907262:0.761432:0.524242:0.761432:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
including use in halothane anaesthesia where :@0.524242:0.791991:0.907243:0.791991:0.907243:0.777002:0.524242:0.777002:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
hypotension technique indicated:@0.524242:0.807562:0.779493:0.807562:0.779493:0.792573:0.524242:0.792573:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage::@0.524242:0.827604:0.593669:0.827604:0.593669:0.811213:0.524242:0.811213:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.593668:0.821825:0.599894:0.821825:0.599894:0.812269:0.593668:0.812269:0.000000
200 mg in 200 ml normal saline or dextrose :@0.524242:0.843185:0.907301:0.843185:0.907301:0.828196:0.524242:0.828196:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
and water infusion and administer at 1 mg/ml :@0.524242:0.858756:0.907243:0.858756:0.907243:0.843767:0.524242:0.843767:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903029:0.858756:0.907243:0.858756:0.907243:0.843767:0.903029:0.843767:0.000000
:@0.524242:0.873810:0.533055:0.873810:0.533055:0.859126:0.524242:0.859126:0.000000
  administer via paediatric 50 ml graduated :@0.533055:0.874326:0.907262:0.874326:0.907262:0.859338:0.533055:0.859338:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
burette to facilitate accurate dose    rate of Iv :@0.524261:0.889897:0.907281:0.889897:0.907281:0.874908:0.524261:0.874908:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.806162:0.889381:0.814976:0.889381:0.814976:0.874697:0.806162:0.874697:0.000000
infusion 2 mg/min until satisfactory response and :@0.524261:0.905468:0.907281:0.905468:0.907281:0.890479:0.524261:0.890479:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
then stopped, usually within range of 50-200 mg :@0.524261:0.921038:0.907301:0.921038:0.907301:0.906050:0.524261:0.906050:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903048:0.921038:0.907262:0.921038:0.907262:0.906050:0.903048:0.906050:0.000000
:@0.524261:0.936093:0.533074:0.936093:0.533074:0.921409:0.524261:0.921409:0.000000
  Hypotensive  anaesthesia:  Induce  anaesthesia :@0.533074:0.936609:0.907243:0.936609:0.907243:0.921621:0.533074:0.921621:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000